Sandra Horning
Directeur/Membre du Conseil chez GILEAD SCIENCES, INC.
Fortune : 4 M $ au 30/04/2024
Profil
Sandra J.
Horning is the founder of EQRx International, Inc. (founded in 2020) and EQRx, Inc. (founded in 2019).
She is currently an Independent Director at Gilead Sciences, Inc., Revolution Medicines, Inc., Olema Pharmaceuticals, Inc., Moderna, Inc., and Cellarity Inc. She is also a Professor at Stanford University School of Medicine.
Previously, she held positions as a Director at Foundation Medicine, Inc. (2015-2018), Chief Medical Officer & EVP-Global Development at Genentech, Inc. (2014-2019), Chief Medical Officer at Roche Holdings, Inc. (2009-2019), President at American Society of Clinical Oncology, Inc. (2005-2006), and Chief Medical Officer & Head-Product Development at Roche, Inc. (2013-2019).
Dr. Horning received her undergraduate and doctorate degrees from the University of Iowa.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 31/03/2024 | 90 638 ( 0,06% ) | 3 M $ | 30/04/2024 | |
GILEAD SCIENCES, INC.
0,00% | 08/05/2024 | 3 631 ( 0,00% ) | 236 995 $ | 30/04/2024 |
MODERNA, INC.
0,00% | 06/05/2024 | 1 373 ( 0,00% ) | 145 785 $ | 30/04/2024 |
| 23/04/2024 | 0 ( -.--% ) | - $ | 30/04/2024 |
Postes actifs de Sandra Horning
| Sociétés | Poste | Début |
|---|---|---|
| GILEAD SCIENCES, INC. | Directeur/Membre du Conseil | 28/01/2020 |
| MODERNA, INC. | Directeur/Membre du Conseil | 01/03/2020 |
| OLEMA PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 13/11/2020 |
| REVOLUTION MEDICINES, INC. | Directeur/Membre du Conseil | 09/11/2023 |
| Stanford University School of Medicine | Corporate Officer/Principal | - |
Cellarity Inc.
 Cellarity Inc. BiotechnologyHealth Technology Cellarity Inc. engages in the operation of platform to design medicines targeting the full cellular and molecular complexity of disease. The company was founded by Avak Kahvejian, James J. Collins, Noubar Afeyan, and Nicholas Plugis in 2017 and is headquartered in Cambridge, MA. | Directeur/Membre du Conseil | 09/05/2022 |
Anciens postes connus de Sandra Horning
| Sociétés | Poste | Fin |
|---|---|---|
| EQRX, INC. | Fondateur | 09/11/2023 |
| Roche, Inc. | Directeur Technique/Scientifique/R&D | 01/10/2019 |
Roche Holdings, Inc.
 Roche Holdings, Inc. Financial ConglomeratesFinance Roche Holdings, Inc. operates as a holding company, which engages in the manufacture and distribution of pharmaceutical and vitamin products. It also provides financial services to other members of the RHI Group and to refinance on the bond or loan markets. The company was founded in 1987 and is headquartered in San Francisco, CA. | Directeur Technique/Scientifique/R&D | 01/01/2019 |
| ░░░░░░░░░░ ░░░░░░░░ ░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░░░░ ░░ ░░░░░░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░░ | ░░░░░░░░░░ |
Formation de Sandra Horning
| University of Iowa | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 5 |
|---|---|
| GILEAD SCIENCES, INC. | Health Technology |
| MODERNA, INC. | Health Technology |
| OLEMA PHARMACEUTICALS, INC. | Health Technology |
| EQRX, INC. | Health Technology |
| REVOLUTION MEDICINES, INC. | Health Technology |
| Entreprise privées | 7 |
|---|---|
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
Foundation Medicine, Inc.
 Foundation Medicine, Inc. Medical/Nursing ServicesHealth Services Foundation Medicine, Inc. is a molecular information company, which engages in the provision of information on clinical treatment decisions for patients with cancer. The company was founded on January 10, 2010 and is headquartered in Cambridge, MA. | Health Services |
Roche Holdings, Inc.
Roche Holdings, Inc. Financial ConglomeratesFinance Roche Holdings, Inc. operates as a holding company, which engages in the manufacture and distribution of pharmaceutical and vitamin products. It also provides financial services to other members of the RHI Group and to refinance on the bond or loan markets. The company was founded in 1987 and is headquartered in San Francisco, CA. | Finance |
EQRx International, Inc.
 EQRx International, Inc. Pharmaceuticals: MajorHealth Technology EQRx International, Inc. engages in healthcare services. The firm specializes in remaking medicine services. The company was founded by Peter Bach and Sandra Horning on January 12, 2020 and is headquartered in Cambridge, MA. | Health Technology |
American Society of Clinical Oncology, Inc.
 American Society of Clinical Oncology, Inc. Medical/Nursing ServicesHealth Services The American Society of Clinical Oncology is a non-profit organization founded in 1964 with the overarching goals of improving cancer care and prevention. More than 27,000 oncology practitioners belong to ASCO, representing all oncology disciplines and subspecialties. Members include physicians and health-care professionals in all levels of the practice of oncology. American Society of Clinical Oncology is the world’s leading professional organization representing physicians who treat people with cancer. ASCO’s members set the standard for patient care worldwide and lead the way in carrying out clinical research aimed at improving the prevention, diagnosis, and treatment of cancer. ASCO's efforts are also directed toward advocating for policies that provide access to high-quality care for all patients with cancer and at supporting the increased funding for clinical and translational research. | Health Services |
| Roche, Inc. | |
Cellarity Inc.
Cellarity Inc. BiotechnologyHealth Technology Cellarity Inc. engages in the operation of platform to design medicines targeting the full cellular and molecular complexity of disease. The company was founded by Avak Kahvejian, James J. Collins, Noubar Afeyan, and Nicholas Plugis in 2017 and is headquartered in Cambridge, MA. | Health Technology |